Kinase Inhibitor Market Soars with Remarkable 6.6% CAGR, Reaching a Value of US$ 80.2 billion by 2030

Comments · 141 Views

The report "Kinase Inhibitor Market, By Product (Angiogenesis Inhibitor, mTOR Inhibitor, BRAF & MEK Inhibitor and Others), By Distribution Channel (Hospital Pharmacies, Online Pharmacies and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle Ea

Kinase inhibitor market demonstrates impressive growth, boasting a 6.6% Compound Annual Growth Rate (CAGR), propelling its value to a substantial US$ 80.2 billion by 2030.

The report "Kinase Inhibitor Market, By Product (Angiogenesis Inhibitor, mTOR Inhibitor, BRAF & MEK Inhibitor and Others), By Distribution Channel (Hospital Pharmacies, Online Pharmacies and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030”

Sample link:

https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/4670

Key Highlights:

  • In 2019, JAK inhibitor was launched for the treatment of rheumatoid arthritis which is a combination of tofacitnib and baricitnib. These are small molecule inhibitors of Janus Kinase (JAK) enzymes approved for the treatment.
  • Bemcentinib (BGB324) is in pipeline which is a potent, selective and orally AXL inhibitor and have potential to cure aggressive diseases including therapy resistant cancer.

Analyst view:

According to analysts, the kinase inhibitor market's robust 6.6% CAGR reflects a burgeoning demand for targeted therapies, driving its value to a noteworthy US$ 80.2 billion by 2030 . The market's potential to address various diseases continues to attract attention and investments."

Competitive Landscape:

The key players operating in the global kinase inhibitor market includes Incyte Corporation, Glaxo SmithKline, AstraZeneca, Eisai Co., Ltd., Bristol-Myers Squibb, Bayer AG, Pfizer Inc., Takeda Pharmaceutical Company Limited, Boehringer Ingelheim GmbH, Eisai Co., Ltd., Johnson & Johnson and F. Hoffmann-La Roche Ltd.

The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.

To know more

Contact Us:

Sales

Prophecy Market Insights

 U.S.  1 860 531 2574

RoW: 917775049802

Email- sales@prophecymarketinsights.com

Website- www.prophecymarketinsights.com

Blog- www.prophecyjournals.com

Comments